The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-related advanced fibrosis and cirrhosis in the United States population utilizing AGILE 3 + and AGILE 4 scores: analysis of the NHANES 2017–2018 cycle

Peer Review reports

Original Submission
19 Aug 2023	Submitted	Original manuscript
20 Oct 2023	Reviewed	Reviewer Report
21 Nov 2023	Reviewed	Reviewer Report
19 May 2024	Author responded	Author comments - Naim Alkhouri
26 May 2024	Reviewed	Reviewer Report
7 Jun 2024	Reviewed	Reviewer Report
13 Jun 2024	Author responded	Author comments - Naim Alkhouri
Resubmission - Version 2
19 May 2024	Submitted	Manuscript version 2
Publishing
14 Jun 2024	Editorially accepted
8 Jul 2024	Article published	10.1186/s12876-024-03295-8

Back to article page